Clinical Trial Update: Safety Study of Riluzole to Treat Post-traumatic Stress Disorder (PTSD) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updat e for riluzole safety in PTSD (Phase 1/2) completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Riluzole (riluzole)

Snippet

Sponsor: Uniformed Services University of the Health Sciences | Conditions: PTSD | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-09-25